Browse Title Index


 
Issue Title
 
Vol 2013, No 5 (2013) Concert Pharmaceuticals Snags Celgene as a Partner for its DCE Platform® Abstract
Heather Cartwright
 
Vol 2006, No 77 (2006) Conference Report: Drug Discovery Partnerships and Outsourcing Abstract   pdf
Business Review Editor
 
Vol 2012, No 6 (2012) Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry Abstract
Cynthia Tso, Jansen Jacob
 
Vol 2012, No 2 (2012) Constellation and Genentech Form Broad Epigenetics Collaboration with Buyout Option Abstract
Heather Cartwright
 
Vol 2006, No 76 (2006) Controlling Value in Deals Abstract   html
Fintan Walton
 
Vol 2009, No 10 (2009) Cool Hats Abstract   jpg
Clive Goddard
 
Vol 2003, No 42 (2003) Corgentech Clinches Bristol-Myers Squibb Alliance Abstract   pdf
Business Review Editor
 
Vol 2005, No 56 (2005) Corixa Hands Over Bexxar® Rights to GSK Abstract
Business Review Editor
 
Vol 2013, No 9 (2013) Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi Abstract
Heather Cartwright
 
Vol 2009, No 5 (2009) Cornerstone's Strategic Transaction with Chiesi Abstract
Taskin Ahmed
 
Vol 2022, No 8 (2022) Could Biopharma M&A Activity be on the Rise? Abstract   pdf   html
Lucy Haggerty & Taskin Ahmed
 
Vol 2009, No 3 (2009) Could J&J Trip up the Merck and Schering-Plough Deal? Abstract
Taskin Ahmed
 
Vol 2005, No 64 (2005) Covance Acquires Clinical Services Facility from West Pharmaceutical Abstract   pdf
Business Review Editor
 
Vol 2010, No 9 (2010) Covance Becomes Sanofi-aventis’ R&D Partner Abstract
Heather Cartwright
 
Vol 2009, No 5 (2009) Covidien Acquires VNUS Medical Technologies for US$440 M Abstract
Taskin Ahmed
 
Vol 2020, No 12 (2020) Covis Group Acquires AMAG Pharmaceuticals for US$498 M Abstract   pdf   html
Sasha Yachu & Michelle Liu
 
Vol 2006, No 67 (2006) Crucell and Berna Biotech to Create Large Independent Vaccine Company Abstract   pdf
Business Review Editor
 
Vol 2002, No 28 (2002) Crucell and NatImmune Sign Licensing Agreement Abstract   pdf
Business Review Editor
 
Vol 2006, No 74 (2006) CrystaX Pharmaceuticals SL Abstract
Business Review Editor
 
Vol 2020, No 7 (2020) CSL Behring Licenses Phase III Haemophilia B Gene Therapy Candidate from uniQure Abstract   pdf   html
Sasha Yachu & Michelle Liu
 
Vol 2004, No 44 (2004) CSL Combines with Aventis to Create ZLB Behring Abstract   pdf
Business Review Editor
 
Vol 2021, No 12 (2021) CSL Hands Over US$11.7 B to Acquire Vifor Pharma Abstract   pdf   html
Sasha Yachu
 
Vol 2008, No 99 (2008) CSL Seeks to Solidfy its Position by Acquiring Talecris Abstract   pdf   html
Taskin Ahmed
 
Vol 2013, No 3 (2013) Cubist Gains Option to Acquire Adynxx with Diversification in Mind Abstract
Heather Cartwright
 
Vol 2011, No 11 (2011) Cubist Looks to Opioid Receptor Antagonists with Potential US$415 M Adolor Takeover Abstract
Heather Cartwright
 
Vol 2004, No 50 (2004) CuraGen Licenses Seattle Genetics’ ADC Technology Abstract   pdf
Business Review Editor
 
Vol 2004, No 49 (2004) CuraGen Licenses TopoTarget’s HDAC Inhibitor Abstract   pdf
Business Review Editor
 
Vol 2005, No 59 (2005) Curis and Genentech Join Forces Again Abstract   pdf
Business Review Editor
 
Vol 2022, No 2 (2022) Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform Abstract   pdf   html
Ayush Saxena & Lucy Haggerty
 
Vol 2008, No 100 (2008) CV Therapeutics Aims High Through its Agreement with Menarini Abstract   pdf   html
Sally Mardikian PhD
 
Vol 2018, No 7 (2018) CVC Capital Acquires Controlling Stake in Recordati Abstract   pdf   html
Jasmine Kalsi
 
Vol 2005, No 64 (2005) Cyto Pulse Collaborates with US Army Abstract   pdf
Business Review Editor
 
Vol 2007, No 80 (2007) Cytokinetics and Amgen Enter into Collaboration for Heart Failure Abstract   pdf
Business Review Editor
 
Vol 2013, No 7 (2013) Cytokinetics Gains Astellas as Partner in Field of Skeletal Muscle Activation Abstract
Heather Cartwright
 
Vol 2008, No 99 (2008) Cytos Signs Vaccines Deal with Pfizer Abstract   pdf   html
Taskin Ahmed
 
Vol 2007, No 82 (2007) Cytyc - A Positive Outlook Abstract   pdf
Business Review Editor
 
Vol 2005, No 61 (2005) Dacogen (decitabine) Abstract   pdf
Business Review Editor
 
Vol 2012, No 3 (2012) Daiichi Sankyo and GSK to Establish Vaccines Joint Venture in Japan Abstract
Heather Cartwright
 
Vol 2008, No 96 (2008) Daiichi Sankyo Boosts Oncology Portfolio with Acquisition of Biotech, U3 Pharma Abstract   pdf   html
Helen Scrutton
 
Vol 2008, No 97 (2008) Daiichi Sankyo Diversifies into Generics through Major Investment in Indian Giant Abstract   pdf   html
Sally Mardikian PhD
 
Vol 2011, No 3 (2011) Daiichi Sankyo Targets US Oncology Market with US$935 M Plexxikon Acquisition Abstract
Heather Cartwright
 
Vol 2005, No 55 (2005) Dainippon and Sumitomo Follow in the Footsteps of Yamanouchi and Fujisawa Abstract   pdf
Business Review Editor
 
Vol 2013, No 4 (2013) Dainippon Sumitomo Licenses Japanese Rights to Two Redox-Directed Drugs from Edison Pharmaceuticals Abstract
Heather Cartwright
 
Vol 2012, No 3 (2012) Dainippon Sumitomo Pharma Expands its Oncology Presence with Boston Biomedical Acquisition Abstract
Heather Cartwright
 
Vol 2021, No 7 (2021) Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition Abstract   pdf   html
Debadrita Paul
 
Vol 2005, No 58 (2005) De Novo Pharmaceuticals Ltd Abstract
Business Review Editor
 
Vol 2007, No 83 (2007) Deal box Details   jpg
Business Review Editor
 
Vol 2005, No 56 (2005) Deal Making in the Biopharmaceutical Sector Abstract   pdf
Business Review Editor
 
Vol 2002, No 31 (2002) Deal Making in the Drug Delivery Sector Abstract
Business Review Editor
 
Vol 2006, No 68 (2006) Deal Making in the New Healthcare Landscape Abstract   pdf
Business Review Editor
 
Vol 2002, No 25 (2002) Deal Making in the Pharmaceutical Fine Chemical Industry Abstract
Business Review Editor
 
Vol 2006, No 74 (2006) Deal Making Review: 2000-2005, with Projections for 2006 Abstract   pdf
Business Review Editor
 
Vol 2006, No 72 (2006) Deal Making Spotlights on Big Pharma Abstract   pdf
Business Review Editor
 
Vol 2009, No 9 (2009) Deal Making Trends in Oncology Abstract
Josef Walker
 
Vol 2005, No 59 (2005) Deal Making Trends of Top Pharma Companies Abstract   pdf
Business Review Editor
 
Vol 2006, No 73 (2006) Deal termination Details   jpg
Business Review Editor
 
Vol 2019, No 12 (2019) Deal Trends in Gene Therapy Abstract   pdf
Michelle Liu & Taskin Ahmed
 
Vol 2019, No 1 (2019) Deal Trends in Immuno-Oncology Abstract   pdf
Natasha Piper, Heather Cartwright & Taskin Ahmed
 
Vol 2006, No 69 (2006) Dealing with Litigation Abstract
Business Review Editor
 
Vol 2010, No 1 (2010) Dealing with the Wolf Abstract   jpg
Clive Goddard
 
Vol 2012, No 1 (2012) Decision Maker Abstract   jpg
Clive Goddard
 
Vol 2018, No 12 (2018) Decline in Big Pharma Deal Activity Mirrors Industry-wide Slowdown in Dealmaking Abstract   pdf
Jawala Prasad & Jasmine Kalsi
 
Vol 2002, No 25 (2002) Degussa AG divests pharmaceutical interests Abstract   pdf
Business Review Editor
 
Vol 2007, No 88 (2007) Delivering Success from Seed Capital Investment Abstract   pdf
Business Review Editor
 
Vol 2004, No 51 (2004) Deltanoid’s and Abbott’s Renal Partnership Abstract
Business Review Editor
 
Vol 2018, No 6 (2018) Denali Therapeutics Exercises Option to Acquire F-Star Gamma Abstract   pdf   html
Natasha Piper
 
Vol 2002, No 28 (2002) Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform Abstract   pdf
Business Review Editor
 
Vol 2003, No 34 (2003) Dendreon to Acquire Corvas Abstract   pdf
Business Review Editor
 
Vol 2003, No 37 (2003) deVGen NV Abstract   pdf
Business Review Editor
 
Vol 2002, No 28 (2002) Diacrin Licenses Transplantation Technology to Terumo Abstract   pdf
Business Review Editor
 
Vol 2006, No 69 (2006) Diagnose This Abstract   html
Fintan Walton
 
Vol 2006, No 74 (2006) Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off Abstract   pdf
Business Review Editor
 
Vol 2006, No 72 (2006) Diquafosol Abstract   pdf
Business Review Editor
 
Vol 2006, No 69 (2006) Divestments and Acquisitions: A Changing Landscape Abstract   pdf
Business Review Editor
 
Vol 2005, No 60 (2005) Dividing Opinion: Shire's Move to Purchase TKT Abstract   pdf
Business Review Editor
 
Vol 2005, No 61 (2005) Don't Make Your Drug Deals Poison Pills Details   html
Fintan Walton
 
Vol 2007, No 86 (2007) Dong Wha Goes Global with P&G Abstract   pdf
Business Review Editor
 
Vol 2008, No 94 (2008) Dr. Reddy's Acquisition Sweeps through Europe Abstract   pdf   html
Sally Mardikian PhD
 
Vol 2006, No 69 (2006) Dr. Reddy’s Acquires betapharm to Expand European Operations Abstract   pdf
Business Review Editor
 
Vol 2006, No 76 (2006) Drastic Measures: Ligand Sells All its Marketed Products Abstract   pdf
Business Review Editor
 
Vol 2003, No 33 (2003) Drug Delivery Alliance Development Process Abstract
Business Review Editor
 
Vol 2002, No 24 (2002) Drug Royalty Companies Abstract
Business Review Editor
 
Vol 2007, No 79 (2007) Drug Withdrawals: Pfizer the Latest Victim Abstract
Business Review Editor
 
Vol 2002, No 28 (2002) DSM to Acquire Roche’s Vitamins and Fine Chemicals Division Abstract   pdf
Business Review Editor
 
Vol 2006, No 74 (2006) Due Diligence Details   jpg
Business Review Editor
 
Vol 2013, No 1 (2013) Dutch Start-Up Dezima Pharma In-Licenses First Pipeline Drug from Mitsubishi Tanabe Abstract
Heather Cartwright
 
Vol 2009, No 8 (2009) DxS and AstraZeneca Collaborate on Iressa® Diagnostic Abstract
Taskin Ahmed
 
Vol 2009, No 2 (2009) Dyax and Biogen Idec Expand Drug Discovery Deal Abstract   html
Taskin Ahmed
 
Vol 2008, No 94 (2008) Dyax and Cubist Sign Deal for DX-88 Surgical Indications Abstract   pdf   html
Helen Scrutton
 
Vol 2007, No 90 (2007) Dynavax Licenses HBV Vaccine to Merck & Co. Abstract   pdf
Business Review Editor
 
Vol 2008, No 103 (2008) Dynavax’s Deal Termination with Merck is followed by a New Agreement with GSK Abstract   pdf   html
Sally Mardikian PhD
 
Vol 2020, No 5 (2020) Dyno Therapeutics Launches with US$2 B Deals with Novartis and Sarepta Abstract   pdf   html
Michelle Liu
 
Vol 2020, No 10 (2020) Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche Abstract   pdf   html
Pratika Pahwa & Michelle Liu
 
Vol 2023, No 1 (2023) Early Signs of M&A Activity Heating Up in 2023 Abstract   pdf   html
Lucy Haggerty
 
Vol 2006, No 77 (2006) Eastern Promise Abstract   html
Fintan Walton
 
Vol 2008, No 92 (2008) Ebay Details   jpg
Business Review Editor
 
Vol 2014, No 2 (2014) Edison and Dainippon Sumitomo Broaden Relationship with Discovery Alliance Targeting Redox Biochemistry Abstract
Heather Cartwright
 
Vol 2008, No 94 (2008) Effective Benchmarking Abstract
Business Review Editor
 
Vol 2014, No 3 (2014) Eisai and Biogen Idec Partner to Advance Alzheimer’s Disease Drug Candidates Abstract
Heather Cartwright
 
Vol 2016, No 2 (2016) Eisai Bolsters Oncology Pipeline by Acquiring Rights to Huya’s Cancer Drug Abstract   pdf   html
Jasmine Kalsi & Taskin Ahmed
 
901 - 1000 of 2581 Items << < 5 6 7 8 9 10 11 12 13 14 > >>